M&A Deal Summary |
|
|---|---|
| Date | 2017-04-20 |
| Target | Upsher-Smith Laboratories - Generics Business |
| Sector | Life Science |
| Buyer(s) | Sawai Pharmaceutical Co. |
| Sellers(s) | Upsher-Smith Laboratories |
| Deal Type | Divestiture |
| Deal Value | 1.1B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1929 |
| Sector | Life Science |
| Employees | 1,490 |
Sawai Pharmaceutical Co. Ltd. is a generic pharmaceuticals manufacturer. Sawai Pharmaceutical was founded in 1929 and is based in Osaka, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Minnesota M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2017 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1919 |
| Sector | Life Science |
Upsher-Smith Laboratories is a pharmaceutical company, that delivers quality therapies and solutions that measurably improve individuals’ lives. Upsher-Smith Laboratories is based in Maple Grove, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: Minnesota M&A | 2 of 2 |
| Country: United States M&A | 2 of 2 |
| Year: 2017 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-12-19 |
AmLactin
Maple Grove, Minnesota, United States AmLactin is a developer, manufacturer of skin care products including therapeutic moisturizers and conditioners. AmLactin is based in Maple Grove, Minnesota. |
Sell | - |